APO Research
Talk to an analyst

APO RESEARCH · REPORT

Intravenous (IV) Solution

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Intravenous (IV) Solution Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

20 December 2025188 pages

Choose your research edition.

Industry ResearchIntravenous (IV) Solution Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Intravenous (IV) Solution Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Intravenous (IV) Solution Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Intravenous (IV) Solution Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Intravenous (IV) Solution Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Intravenous (IV) Solution market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Intravenous (IV) Solution is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Intravenous (IV) Solution is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Intravenous (IV) Solution is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Intravenous (IV) Solution is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Intravenous (IV) Solution include Amanta Healthcare, B. Braun Melsungen, Grifols, ICU Medical, Terumo Medical, Baxter and Fresenius Kabi, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Intravenous (IV) Solution market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Intravenous (IV) Solution and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Intravenous (IV) Solution sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Intravenous (IV) Solution market size, projected growth trends, production technologies, key applications, and end-use industries.

Intravenous (IV) Solution Segment by Company

Amanta Healthcare

B. Braun Melsungen

Grifols

ICU Medical

Terumo Medical

Baxter

Fresenius Kabi

Intravenous (IV) Solution Segment by Type

Peripheral Parenteral Nutrition

Total Parenteral Nutrition

Intravenous (IV) Solution Segment by Application

Hospital & Clinics

Ambulatory

Home Care

Intravenous (IV) Solution Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Intravenous (IV) Solution market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Intravenous (IV) Solution and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Intravenous (IV) Solution.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Intravenous (IV) Solution market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Intravenous (IV) Solution manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Intravenous (IV) Solution in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Intravenous (IV) Solution in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Intravenous (IV) Solution Industry Trends Table 2. Intravenous (IV) Solution Industry Drivers Table 3. Intravenous (IV) Solution Industry Opportunities and Challenges Table 4. Intravenous (IV) Solution Industry Restraints Table 5. Global Intravenous (IV) Solution Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Intravenous (IV) Solution Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Intravenous (IV) Solution Sales by Manufacturers (W Tons) & (2021-2026) Table 8. Global Intravenous (IV) Solution Sales Market Share by Manufacturers Table 9. Global Intravenous (IV) Solution Average Sales Price (US$/Ton) of Manufacturers (2021-2026) Table 10. Global Intravenous (IV) Solution Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Intravenous (IV) Solution Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Intravenous (IV) Solution Manufacturers, Product Type & Application Table 13. Global Intravenous (IV) Solution Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Intravenous (IV) Solution by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Peripheral Parenteral Nutrition Table 17. Major Manufacturers of Total Parenteral Nutrition Table 18. Global Intravenous (IV) Solution Sales by Type 2021 VS 2025 VS 2032 (W Tons) Table 19. Global Intravenous (IV) Solution Sales by Type (2021-2026) & (W Tons) Table 20. Global Intravenous (IV) Solution Sales by Type (2027-2032) & (W Tons) Table 21. Global Intravenous (IV) Solution Sales Market Share by Type (2021-2026) Table 22. Global Intravenous (IV) Solution Sales Market Share by Type (2027-2032) Table 23. Global Intravenous (IV) Solution Revenue by Type 2021 VS 2025 VS 2032 (W Tons) Table 24. Global Intravenous (IV) Solution Revenue by Type (2021-2026) & (W Tons) Table 25. Global Intravenous (IV) Solution Revenue by Type (2027-2032) & (W Tons) Table 26. Global Intravenous (IV) Solution Revenue Market Share by Type (2021-2026) Table 27. Global Intravenous (IV) Solution Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital & Clinics Table 29. Major Manufacturers of Ambulatory Table 30. Major Manufacturers of Home Care Table 31. Global Intravenous (IV) Solution Sales by Application 2021 VS 2025 VS 2032 (W Tons) Table 32. Global Intravenous (IV) Solution Sales by Application (2021-2026) & (W Tons) Table 33. Global Intravenous (IV) Solution Sales by Application (2027-2032) & (W Tons) Table 34. Global Intravenous (IV) Solution Sales Market Share by Application (2021-2026) Table 35. Global Intravenous (IV) Solution Sales Market Share by Application (2027-2032) Table 36. Global Intravenous (IV) Solution Revenue by Application 2021 VS 2025 VS 2032 (W Tons) Table 37. Global Intravenous (IV) Solution Revenue by Application (2021-2026) & (W Tons) Table 38. Global Intravenous (IV) Solution Revenue by Application (2027-2032) & (W Tons) Table 39. Global Intravenous (IV) Solution Revenue Market Share by Application (2021-2026) Table 40. Global Intravenous (IV) Solution Revenue Market Share by Application (2027-2032) Table 41. Global Intravenous (IV) Solution Sales by Region: 2021 VS 2025 VS 2032 (W Tons) Table 42. Global Intravenous (IV) Solution Sales by Region (2021-2026) & (W Tons) Table 43. Global Intravenous (IV) Solution Sales Market Share by Region (2021-2026) Table 44. Global Intravenous (IV) Solution Sales Forecasted by Region (2027-2032) & (W Tons) Table 45. Global Intravenous (IV) Solution Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Intravenous (IV) Solution Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Tons) Table 47. North America Intravenous (IV) Solution Sales by Country (2021-2026) & (W Tons) Table 48. North America Intravenous (IV) Solution Sales by Country (2027-2032) & (W Tons) Table 49. Europe Intravenous (IV) Solution Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Tons) Table 50. Europe Intravenous (IV) Solution Sales by Country (2021-2026) & (W Tons) Table 51. Europe Intravenous (IV) Solution Sales by Country (2027-2032) & (W Tons) Table 52. Asia Pacific Intravenous (IV) Solution Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Tons) Table 53. Asia Pacific Intravenous (IV) Solution Sales by Country (2021-2026) & (W Tons) Table 54. Asia Pacific Intravenous (IV) Solution Sales by Country (2027-2032) & (W Tons) Table 55. South America, Middle East and Africa Intravenous (IV) Solution Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Tons) Table 56. South America, Middle East and Africa Intravenous (IV) Solution Sales by Country (2021-2026) & (W Tons) Table 57. South America, Middle East and Africa Intravenous (IV) Solution Sales by Country (2027-2032) & (W Tons) Table 58. Global Intravenous (IV) Solution Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Intravenous (IV) Solution Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Intravenous (IV) Solution Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Intravenous (IV) Solution Revenue Market Share by Region (2021-2026) Table 62. Global Intravenous (IV) Solution Revenue Market Share by Region (2027-2032) Table 63. Amanta Healthcare Company Information Table 64. Amanta Healthcare Business Overview Table 65. Amanta Healthcare Intravenous (IV) Solution Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Amanta Healthcare Intravenous (IV) Solution Product Portfolio Table 67. Amanta Healthcare Recent Development Table 68. B. Braun Melsungen Company Information Table 69. B. Braun Melsungen Business Overview Table 70. B. Braun Melsungen Intravenous (IV) Solution Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. B. Braun Melsungen Intravenous (IV) Solution Product Portfolio Table 72. B. Braun Melsungen Recent Development Table 73. Grifols Company Information Table 74. Grifols Business Overview Table 75. Grifols Intravenous (IV) Solution Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Grifols Intravenous (IV) Solution Product Portfolio Table 77. Grifols Recent Development Table 78. ICU Medical Company Information Table 79. ICU Medical Business Overview Table 80. ICU Medical Intravenous (IV) Solution Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. ICU Medical Intravenous (IV) Solution Product Portfolio Table 82. ICU Medical Recent Development Table 83. Terumo Medical Company Information Table 84. Terumo Medical Business Overview Table 85. Terumo Medical Intravenous (IV) Solution Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Terumo Medical Intravenous (IV) Solution Product Portfolio Table 87. Terumo Medical Recent Development Table 88. Baxter Company Information Table 89. Baxter Business Overview Table 90. Baxter Intravenous (IV) Solution Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Baxter Intravenous (IV) Solution Product Portfolio Table 92. Baxter Recent Development Table 93. Fresenius Kabi Company Information Table 94. Fresenius Kabi Business Overview Table 95. Fresenius Kabi Intravenous (IV) Solution Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Fresenius Kabi Intravenous (IV) Solution Product Portfolio Table 97. Fresenius Kabi Recent Development Table 98. Key Raw Materials Table 99. Raw Materials Key Suppliers Table 100. Intravenous (IV) Solution Distributors List Table 101. Intravenous (IV) Solution Customers List Table 102. Research Programs/Design for This Report Table 103. Authors List of This Report Table 104. Secondary Sources Table 105. Primary Sources List of Figures Figure 1. Intravenous (IV) Solution Product Image Figure 2. Global Intravenous (IV) Solution Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Intravenous (IV) Solution Market Size (2021-2032) & (US$ Million) Figure 4. Global Intravenous (IV) Solution Sales (2021-2032) & (W Tons) Figure 5. Global Intravenous (IV) Solution Average Price (US$/Ton) & (2021-2032) Figure 6. Global Top 5 and 10 Intravenous (IV) Solution Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Peripheral Parenteral Nutrition Image Figure 9. Total Parenteral Nutrition Image Figure 10. Global Intravenous (IV) Solution Sales by Type (2021 VS 2025 VS 2032) & (W Tons) Figure 11. Global Intravenous (IV) Solution Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Intravenous (IV) Solution Sales Market Share by Type (2021-2032) Figure 13. Global Intravenous (IV) Solution Revenue by Type (2021 VS 2025 VS 2032) & (W Tons) Figure 14. Global Intravenous (IV) Solution Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Intravenous (IV) Solution Revenue Market Share by Type (2021-2032) Figure 16. Hospital & Clinics Image Figure 17. Ambulatory Image Figure 18. Home Care Image Figure 19. Global Intravenous (IV) Solution Sales by Application (2021 VS 2025 VS 2032) & (W Tons) Figure 20. Global Intravenous (IV) Solution Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Intravenous (IV) Solution Sales Market Share by Application (2021-2032) Figure 22. Global Intravenous (IV) Solution Revenue by Application (2021 VS 2025 VS 2032) & (W Tons) Figure 23. Global Intravenous (IV) Solution Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Intravenous (IV) Solution Revenue Market Share by Application (2021-2032) Figure 25. North America Intravenous (IV) Solution Sales and Growth Rate (2021-2032) & (W Tons) Figure 26. North America Intravenous (IV) Solution Sales Market Share by Country (2021-2032) Figure 27. U.S. Intravenous (IV) Solution Sales and Growth Rate (2021-2032) & (W Tons) Figure 28. Canada Intravenous (IV) Solution Sales and Growth Rate (2021-2032) & (W Tons) Figure 29. Mexico Intravenous (IV) Solution Sales and Growth Rate (2021-2032) & (W Tons) Figure 30. Europe Intravenous (IV) Solution Sales and Growth Rate (2021-2032) & (W Tons) Figure 31. Europe Intravenous (IV) Solution Sales Market Share by Country (2021-2032) Figure 32. Germany Intravenous (IV) Solution Sales and Growth Rate (2021-2032) & (W Tons) Figure 33. France Intravenous (IV) Solution Sales and Growth Rate (2021-2032) & (W Tons) Figure 34. U.K. Intravenous (IV) Solution Sales and Growth Rate (2021-2032) & (W Tons) Figure 35. Italy Intravenous (IV) Solution Sales and Growth Rate (2021-2032) & (W Tons) Figure 36. Netherlands Intravenous (IV) Solution Sales and Growth Rate (2021-2032) & (W Tons) Figure 37. Asia Pacific Intravenous (IV) Solution Sales and Growth Rate (2021-2032) & (W Tons) Figure 38. Asia Pacific Intravenous (IV) Solution Sales Market Share by Country (2021-2032) Figure 39. China Intravenous (IV) Solution Sales and Growth Rate (2021-2032) & (W Tons) Figure 40. Japan Intravenous (IV) Solution Sales and Growth Rate (2021-2032) & (W Tons) Figure 41. South Korea Intravenous (IV) Solution Sales and Growth Rate (2021-2032) & (W Tons) Figure 42. Southeast Asia Intravenous (IV) Solution Sales and Growth Rate (2021-2032) & (W Tons) Figure 43. India Intravenous (IV) Solution Sales and Growth Rate (2021-2032) & (W Tons) Figure 44. Australia Intravenous (IV) Solution Sales and Growth Rate (2021-2032) & (W Tons) Figure 45. South America, Middle East and Africa Intravenous (IV) Solution Sales and Growth Rate (2021-2032) & (W Tons) Figure 46. South America, Middle East and Africa Intravenous (IV) Solution Sales Market Share by Country (2021-2032) Figure 47. Brazil Intravenous (IV) Solution Sales and Growth Rate (2021-2032) & (W Tons) Figure 48. South Africa Intravenous (IV) Solution Sales and Growth Rate (2021-2032) & (W Tons) Figure 49. Saudi Arabia Intravenous (IV) Solution Sales and Growth Rate (2021-2032) & (W Tons) Figure 50. Turkey Intravenous (IV) Solution Sales and Growth Rate (2021-2032) & (W Tons) Figure 51. Argentina Intravenous (IV) Solution Sales and Growth Rate (2021-2032) & (W Tons) Figure 52. UAE Intravenous (IV) Solution Sales and Growth Rate (2021-2032) & (W Tons) Figure 53. Egypt Intravenous (IV) Solution Sales and Growth Rate (2021-2032) & (W Tons) Figure 54. Chile Intravenous (IV) Solution Sales and Growth Rate (2021-2032) & (W Tons) Figure 55. Global Intravenous (IV) Solution Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Intravenous (IV) Solution Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Intravenous (IV) Solution Revenue (2021-2032) & (US$ Million) Figure 58. North America Intravenous (IV) Solution Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Intravenous (IV) Solution Revenue (2021-2032) & (US$ Million) Figure 60. Europe Intravenous (IV) Solution Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Intravenous (IV) Solution Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Intravenous (IV) Solution Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Intravenous (IV) Solution Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Intravenous (IV) Solution Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Intravenous (IV) Solution Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Intravenous (IV) Solution Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Peripheral Parenteral Nutrition
  • Total Parenteral Nutrition
Applications
  • Hospital & Clinics
  • Ambulatory
  • Home Care
Companies covered
  • Amanta Healthcare
  • B. Braun Melsungen
  • Grifols
  • ICU Medical
  • Terumo Medical
  • Baxter
  • Fresenius Kabi

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Intravenous (IV) Solution Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Intravenous (IV) Solution Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Intravenous (IV) Solution Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Intravenous (IV) Solution Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Intravenous (IV) Solution Market Dynamics
  1. 2.1 Intravenous (IV) Solution Industry Trends
  2. 2.2 Intravenous (IV) Solution Industry Drivers
  3. 2.3 Intravenous (IV) Solution Industry Opportunities and Challenges
  4. 2.4 Intravenous (IV) Solution Industry Restraints
3 Intravenous (IV) Solution Market by Manufacturers
  1. 3.1 Global Intravenous (IV) Solution Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Intravenous (IV) Solution Sales by Manufacturers (2021-2026)
  3. 3.3 Global Intravenous (IV) Solution Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Intravenous (IV) Solution Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Intravenous (IV) Solution Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Intravenous (IV) Solution Manufacturers, Product Type & Application
  7. 3.7 Global Intravenous (IV) Solution Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Intravenous (IV) Solution Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Intravenous (IV) Solution Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Intravenous (IV) Solution Tier 1, Tier 2, and Tier 3
4 Intravenous (IV) Solution Market by Type
  1. 4.1 Intravenous (IV) Solution Type Introduction
  2. 4.1.1 Peripheral Parenteral Nutrition
  3. 4.1.2 Total Parenteral Nutrition
  4. 4.2 Global Intravenous (IV) Solution Sales by Type
  5. 4.2.1 Global Intravenous (IV) Solution Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Intravenous (IV) Solution Sales by Type (2021-2032)
  7. 4.2.3 Global Intravenous (IV) Solution Sales Market Share by Type (2021-2032)
  8. 4.3 Global Intravenous (IV) Solution Revenue by Type
  9. 4.3.1 Global Intravenous (IV) Solution Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Intravenous (IV) Solution Revenue by Type (2021-2032)
  11. 4.3.3 Global Intravenous (IV) Solution Revenue Market Share by Type (2021-2032)
5 Intravenous (IV) Solution Market by Application
  1. 5.1 Intravenous (IV) Solution Application Introduction
  2. 5.1.1 Hospital & Clinics
  3. 5.1.2 Ambulatory
  4. 5.1.3 Home Care
  5. 5.2 Global Intravenous (IV) Solution Sales by Application
  6. 5.2.1 Global Intravenous (IV) Solution Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Intravenous (IV) Solution Sales by Application (2021-2032)
  8. 5.2.3 Global Intravenous (IV) Solution Sales Market Share by Application (2021-2032)
  9. 5.3 Global Intravenous (IV) Solution Revenue by Application
  10. 5.3.1 Global Intravenous (IV) Solution Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Intravenous (IV) Solution Revenue by Application (2021-2032)
  12. 5.3.3 Global Intravenous (IV) Solution Revenue Market Share by Application (2021-2032)
6 Global Intravenous (IV) Solution Sales by Region
  1. 6.1 Global Intravenous (IV) Solution Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Intravenous (IV) Solution Sales by Region (2021-2032)
  3. 6.2.1 Global Intravenous (IV) Solution Sales by Region (2021-2026)
  4. 6.2.2 Global Intravenous (IV) Solution Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Intravenous (IV) Solution Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Intravenous (IV) Solution Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Intravenous (IV) Solution Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Intravenous (IV) Solution Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Intravenous (IV) Solution Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Intravenous (IV) Solution Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Intravenous (IV) Solution Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Intravenous (IV) Solution Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Intravenous (IV) Solution Revenue by Region
  1. 7.1 Global Intravenous (IV) Solution Revenue by Region
  2. 7.1.1 Global Intravenous (IV) Solution Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Intravenous (IV) Solution Revenue by Region (2021-2026)
  4. 7.1.3 Global Intravenous (IV) Solution Revenue by Region (2027-2032)
  5. 7.1.4 Global Intravenous (IV) Solution Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Intravenous (IV) Solution Revenue (2021-2032)
  8. 7.2.2 North America Intravenous (IV) Solution Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Intravenous (IV) Solution Revenue (2021-2032)
  11. 7.3.2 Europe Intravenous (IV) Solution Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Intravenous (IV) Solution Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Intravenous (IV) Solution Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Intravenous (IV) Solution Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Intravenous (IV) Solution Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Amanta Healthcare
  2. 8.1.1 Amanta Healthcare Company Information
  3. 8.1.2 Amanta Healthcare Business Overview
  4. 8.1.3 Amanta Healthcare Intravenous (IV) Solution Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Amanta Healthcare Intravenous (IV) Solution Product Portfolio
  6. 8.1.5 Amanta Healthcare Recent Developments
  7. 8.2 B. Braun Melsungen
  8. 8.2.1 B. Braun Melsungen Company Information
  9. 8.2.2 B. Braun Melsungen Business Overview
  10. 8.2.3 B. Braun Melsungen Intravenous (IV) Solution Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 B. Braun Melsungen Intravenous (IV) Solution Product Portfolio
  12. 8.2.5 B. Braun Melsungen Recent Developments
  13. 8.3 Grifols
  14. 8.3.1 Grifols Company Information
  15. 8.3.2 Grifols Business Overview
  16. 8.3.3 Grifols Intravenous (IV) Solution Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Grifols Intravenous (IV) Solution Product Portfolio
  18. 8.3.5 Grifols Recent Developments
  19. 8.4 ICU Medical
  20. 8.4.1 ICU Medical Company Information
  21. 8.4.2 ICU Medical Business Overview
  22. 8.4.3 ICU Medical Intravenous (IV) Solution Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 ICU Medical Intravenous (IV) Solution Product Portfolio
  24. 8.4.5 ICU Medical Recent Developments
  25. 8.5 Terumo Medical
  26. 8.5.1 Terumo Medical Company Information
  27. 8.5.2 Terumo Medical Business Overview
  28. 8.5.3 Terumo Medical Intravenous (IV) Solution Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Terumo Medical Intravenous (IV) Solution Product Portfolio
  30. 8.5.5 Terumo Medical Recent Developments
  31. 8.6 Baxter
  32. 8.6.1 Baxter Company Information
  33. 8.6.2 Baxter Business Overview
  34. 8.6.3 Baxter Intravenous (IV) Solution Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Baxter Intravenous (IV) Solution Product Portfolio
  36. 8.6.5 Baxter Recent Developments
  37. 8.7 Fresenius Kabi
  38. 8.7.1 Fresenius Kabi Company Information
  39. 8.7.2 Fresenius Kabi Business Overview
  40. 8.7.3 Fresenius Kabi Intravenous (IV) Solution Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Fresenius Kabi Intravenous (IV) Solution Product Portfolio
  42. 8.7.5 Fresenius Kabi Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Intravenous (IV) Solution Value Chain Analysis
  2. 9.1.1 Intravenous (IV) Solution Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Intravenous (IV) Solution Production Mode & Process
  6. 9.2 Intravenous (IV) Solution Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Intravenous (IV) Solution Distributors
  9. 9.2.3 Intravenous (IV) Solution Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst